نتایج جستجو برای: atll

تعداد نتایج: 284  

2014
Kevin M. Shannon

2482 INSIGHTS | The Journal of Experimental Medicine Malaria is caused by Plasmodium parasites and is commonly thought of as a disease resulting from the cyclic infection and destruction of red blood cells. However, a subset of infected individuals will develop “cerebral malaria”—a pathogenic neuroinflammation, presumably caused by parasitized red blood cells sequestering in the brain. Those af...

Journal: :The Tohoku journal of experimental medicine 2017
Tareg Omer Mohammed Haorile Chagan-Yasutan Yugo Ashino Wakana Nakayama Yayoi Takahashi Taizo Shimomura Tetsuhiro Fujimoto Yuko Watanabe Toshiro Niki Hitoshi Suzushima Toshio Hattori

Adult T-cell leukemia/lymphoma (ATL/ATLL) is one of the most malignant lymphomas with poor prognosis. ATL/ATLL cells express CC chemokine receptor 4, and mogamulizumab (anti-CCR4 monoclonal antibody) exhibits strong cytotoxicity for ATL/ATLL cells. We analyzed plasma samples of 6 patients with ATL/ATLL treated with chemotherapy followed by mogamulizumab therapy (mogatherapy) for changes in the ...

Journal: :American journal of clinical pathology 2005
Taiji Yokote Toshikazu Akioka Satoko Oka Satoshi Hara Kichinosuke Kobayashi Hideto Nakajima Takeshi Yamano Toshiyuki Ikemoto Akira Shimizu Motomu Tsuji Toshiaki Hanafusa

Adult T-cell leukemia/lymphoma (ATLL) is a lymphoproliferative neoplasm of helper T lymphocytes caused by human T-cell leukemia virus type-1 (HTLV-1). The disease was first described in Kyushu, in southwestern Japan, and most frequently occurs in endemic areas, such as Japan, the Caribbean basin, West Africa, Brazil, and northern Iran. ATLL is essentially a disease of adults, characterized clin...

2011
Ana B. Guimaraes-Correa Lindsey B. Crawford Carlos R. Figueiredo Karina P. Gimenes Lorena A. Pinto Maria Fernanda Rios Grassi Gerold Feuer Luiz R. Travassos Antonio C.F. Caires Elaine G. Rodrigues Susan J. Marriott

Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infected with the human T lymphotropic virus type 1 (HTLV-1). Patients with aggressive ATLL have a poor prognosis because the leukemic cells are resistant to conventional chemotherapy. We have investigated the therapeutic efficacy of a biphosphinic cyclopalladated complex {Pd(2) [S(-)C(2), N-dmpa](2)...

Journal: :Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2012
M Popescu Viola Popov G Popescu Camelia Dobrea Aurelia Sandu V T Grigorean V Strâmbu I E Pleşea

UNLABELLED Acute pancreatitis is a common complication, which occurs with patients suffering from vesicular biliary lithiasis or chronic alcoholism. Hypercalcemia may determine acute pancreatitis, its causes being multiple: primary or secondary hyperparathyroidism, metabolic diseases of the bone, metastatic bone neoplasm, as well as lymphoproliferative syndromes caused by the HTLV-1 virus-adult...

2012
Aileen G. Rowan Charles R. M. Bangham

ATLL is an aggressive malignancy of T cells that affects about 5% of individuals infected with HTLV-1. The precise mechanism of oncogenesis is not known, but there is evidence that two regulatory viral proteins, Tax and HBZ, are involved. A high set point proviral load is associated with development of ATLL or a chronic inflammatory condition, HAM/TSP. Several lines of evidence, including HLA c...

Journal: :Cancer research 2014
Céline Vernin Morgan Thenoz Christiane Pinatel Antoine Gessain Olivier Gout Marie-Hélène Delfau-Larue Nicolas Nazaret Catherine Legras-Lachuer Eric Wattel Franck Mortreux

Viruses disrupt the host cell microRNA (miRNA) network to facilitate their replication. Human T-cell leukemia virus type I (HTLV-1) replication relies on the clonal expansion of its host CD4(+) and CD8(+) T cells, yet this virus causes adult T-cell leukemia/lymphoma (ATLL) that typically has a CD4(+) phenotype. The viral oncoprotein Tax, which is rarely expressed in ATLL cells, has long been re...

2011
Daniel A. Rauch Lee Ratner

Of the millions of HTLV-1 infected carriers worldwide, 3-5% will develop an aggressive T-cell neoplasm that is highly refractory to conventional therapy. The virus carries the Tax oncogene which constitutively activates the NFκB pathway. This co-option of signaling through NFκB provides for the HTLV-1 infected cell an escape from cell cycle arrest and apoptosis, a steady source of growth factor...

Journal: :Blood 2011
Marko Pesu

Loss-of-function mutations in Janus kinase 3 (JAK3) are an underlying cause of severe combined immunodeficiency (SCID), whereas hyperactive JAK3 mutants have been identified in hematolocigal malignancies.1-3 In this issue of Blood, Elliot et al place JAK3 again under the magnifying lens and describe novel gain-of-function mutations in the FERM (Founding members: band 4.1, Ezrin, Radixin, and Mo...

Journal: :Journal of Experimental Medicine 2014

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید